Regeneron Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 1.82% to $645.52 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.39% to 4,023.89 and the Dow Jones Industrial Average rising 1.47% to 32,196.66. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $101.90 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.57% to $176.85, Novartis AG ADR (NOVN.EB) rose 0.52% to $85.82, and Amgen Inc. (AMGN) fell 0.54% to $243.40. Trading volume (604,530) remained 67,220 below its 50-day average volume of 671,750.
Data source: Dow Jones Market Data, FactSet. Data compiled May 13, 2022.
(END) Dow Jones Newswires
May 13, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.